MDLN

Medline
D

MDLN

Arincen64/100B

Medline earnings

Medline reports its Q4 FY2026 results on 24 February 2027, before the market opens. Analysts expect earnings per share of 0.39 USD and revenue of 8.50B USD.

In Q3 FY2026, reported on 4 November 2026, Medline earned 0.44 USD a share against the 0.34 USD analysts expected (+28.2%), on revenue of 7.86B USD against 7.72B USD (+1.7%).

Last EPS surprise
+28.2%
Last revenue surprise
+1.7%
Move after the last report
+18.3%
Average move after earnings
10.5%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
0.39 USD
Revenue estimate
8.50B USD
Last quarter · Q3 FY2026
EPS0.44Beat +28.2%Revenue7.86BBeat +1.7%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q3 FY20270.40——-9.15%8.49B——+8.04%—
Q2 FY20270.38——-23.46%8.33B——+8.36%—
Q1 FY20270.34——+3.95%7.88B——+7.21%—
Q4 FY20260.39——+73.56%8.50B——+9.14%—
Q3 FY20260.340.44+28.21%+41.94%7.72B7.86B+1.74%+10.41%+18.3%
Q2 FY20260.350.50+41.88%—7.52B7.69B+2.21%—-12.8%
Q1 FY20260.300.33+11.79%—7.16B7.35B+2.64%—-7.3%
Q4 FY20250.240.22-5.63%—7.51B7.79B+3.66%—-3.7%
Q3 FY2025—0.31———7.12B———

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Beat record

On average, analysts' EPS estimate was 21.9% off the result, either way, and their revenue estimate 2.6%, over the last 4 quarters.

EPS beats
3 / 4
Revenue beats
4 / 4
Average EPS surprise, last 4
+19.1%
Since
February 2026

See also:Forecast,EPS,Income statement

Common questions about Medline's earnings

Source: Financial Modeling Prep